Advertisement
Screener

BridgeBio Oncology Therapeutics, Inc. (BBOT) EBITDA Margin

2.8 / 5 stars · 68/120 Roast Me

BridgeBio Oncology Therapeutics, Inc. EBITDA Margin

No EBITDA Margin for BBOT on this site yet.

Source checked: the stored EBITDA Margin page for BBOT.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78